Best Nootropics for ADHD: 17 Ranked by Evidence
Roon Team

Best Nootropics for ADHD: 17 Ranked by Evidence
Of seventeen nootropics for ADHD most commonly recommended online, only one, omega-3 fatty acids, has multiple controlled trials showing a small, repeatable effect on symptoms. And even that effect fades in the newest pooled data. Zinc, iron, and vitamin D help mainly when you are deficient. Caffeine, the most popular nootropic on the planet, has seven pediatric trials and no measurable benefit for ADHD. Everything else falls somewhere between "promising but tiny" and "no human ADHD data at all."
An estimated 15.5 million U.S. adults carried an ADHD diagnosis in 2023, and the FDA-announced stimulant shortage that began in October 2022 has not fully resolved. That context explains why searches for "natural alternative to Adderall" and "best supplements for ADHD" keep climbing. But interest is not evidence. Below is the evidence.
Key Takeaways
- The ranking criteria are simple: human trials in an ADHD population, sample size, whether the result replicated, and whether the effect held when deficiency was controlled for.
- Nearly every RCT on this list enrolled children. Adult-specific ADHD supplement data barely exists.
- No supplement on this list replaces medication, behavioral therapy, or a clinician's care plan.
- "Natural" is a sourcing claim. It is not an evidence grade.
The Full Ranking: 17 Supplements Graded A Through D
| Rank | Supplement | Grade | Key Trial | n | What Changed | Population |
|---|---|---|---|---|---|---|
| 1 | Omega-3 (EPA/DHA) | A (small, fading) | 2023 meta, 22 RCTs | 1,789 | SMD -0.16 (p=.07); trials over 4 months: SMD -0.35 (p=.007) | Children |
| 2 | Zinc | B (deficiency-conditional) | Bilici 2004 RCT | 400 | Hyperactivity, impulsivity improved; not inattention | Children, Turkey |
| 3 | Pycnogenol | B | Weyns 2022 RCT | 88 | Teacher-rated hyperactivity improved; matched MPH | Children |
| 4 | Saffron | B (no placebo arm) | Baziar 2019 RCT | 54 | Non-inferior to MPH at 6 weeks; no placebo control | Ages 6-17 |
| 5 | Phosphatidylserine | B | Bruton 2021 meta | pooled | Inattention ES 0.36 (p=.01); overall not significant | Children |
| 6 | Vitamin D | B (add-on) | Gan 2019 meta, 4 RCTs | 256 | Small improvement as MPH add-on | Children |
| 7 | Iron | B (low ferritin only) | Konofal 2008 RCT | 23 | ADHD-RS dropped 11 pts vs. placebo rise of 3 (p<.008) | Ages 5-8, ferritin <30 |
| 8 | Ginkgo biloba | B (add-on) | Shakibaei 2015 RCT | 66 | Inattention response: 93.5% vs 58.6% with MPH alone | Ages 6-12 |
| 9 | Melatonin | A (sleep only) | Van der Heijden 2007 RCT | 105 | Sleep onset advanced 27 min; zero effect on daytime behavior | Ages 6-12 |
| 10 | L-theanine | B (sleep) / C (attention) | Lyon 2011 RCT | 98 | Improved sleep efficiency; no daytime symptom outcome | Boys 8-12 |
| 11 | Bacopa monnieri | B (mixed) | Kean 2022 RCT | 93 | No behavioral difference; fewer errors, better cognitive flexibility | Boys 6-14 |
| 12 | Magnesium | C | Hemamy 2021 RCT | 66 | SDQ improved (p=.001), but combined with vitamin D; magnesium's independent effect not separable | Children |
| 13 | Citicoline | C | McGlade 2015 RCT | 75 | Improved attention and psychomotor speed in healthy teens, not ADHD | Healthy adolescents |
| 14 | L-tyrosine | C (transient) | Reimherr 1987 open trial | 12 | 8 of 12 responded at week 2; all 8 lost the effect by week 6 | Adults |
| 15 | Caffeine | A (null) | Perrotte 2023 meta, 7 studies (4 pooled) | 76 (104 screened) | SMD -0.12 (p=.45); no measurable benefit for ADHD symptoms | Ages 5-15 |
| 16 | Rhodiola rosea | D | NCT02737020 | 0 | Trial registered, no results posted | None |
| 17 | Creatine | D | None in ADHD | 0 | No data | None |
How We Graded the Evidence
Each supplement was assigned a letter grade based on the human clinical evidence available as of mid-2026:
- A: Multiple RCTs or at least one meta-analysis in an ADHD population.
- B: One to two RCTs in an ADHD population, or positive results limited to a deficient subgroup.
- C: Open-label data only, tested in a non-ADHD population, or mechanistic evidence without a clinical trial.
- D: No human ADHD data of any kind.
A null trial still counts as evidence. Caffeine earns an A grade because it has been studied enough to conclude it probably does not help. "Deficiency-conditional" is its own category: zinc, iron, and vitamin D showed effects in populations where baseline levels were low, and those effects did not replicate in nutrient-replete subjects. And nearly every RCT above enrolled children, so the adult evidence is thinner than most readers expect.
Tier 1: Small but Repeatable Effects
1. Omega-3 (EPA/DHA)
The strongest evidence on this list, and still modest. A 2023 meta-analysis in the Journal of Clinical Psychiatry pooled 22 RCTs (1,789 participants) and found an overall SMD of -0.16, not reaching significance (p=.07). Trials running four months or longer did reach significance (SMD -0.35, p=.007). An earlier 2018 meta-analysis (7 RCTs, 534 youth) reported a larger effect (g=0.38, p<.0001), and higher EPA doses correlated with better outcomes. The direction is consistent. The size is small and shrinks as more data accumulates. See how DHA and EPA differ.
2. Zinc
Zinc tells a clean story about deficiency. In a Turkish RCT (n=400) where baseline zinc status was lower than typical Western levels, 150 mg/day of zinc sulfate improved hyperactivity and impulsivity over 12 weeks. A U.S. trial (n=52) using 15 mg/day of zinc glycinate found no benefit. A 2021 meta-analysis of 6 RCTs (489 total) reported Hedges' g of -0.62 on total scores (p=.04), but the signal came from the deficiency-heavy cohorts. If your zinc levels are already adequate, the data does not support supplementation for ADHD.
3. Pycnogenol
French maritime pine bark extract. A 2006 RCT (n=61) at 1 mg/kg/day found teacher-rated hyperactivity and inattention improved over four weeks, then returned to baseline one month after stopping. A 2022 head-to-head RCT (n=88) found pycnogenol was better than placebo and not statistically different from methylphenidate on teacher-rated hyperactivity. It did not outperform placebo on inattention. Interesting, but two trials, both in children, both relying on teacher ratings.
4. Saffron
Baziar et al. (2019) randomized 54 children and teens (ages 6-17) to saffron 20-30 mg/day or methylphenidate for six weeks. No difference between groups. That sounds impressive until you notice there was no placebo arm, so we cannot know if either outperformed doing nothing. A 2022 adult add-on trial (n=56) adding saffron to MPH found no benefit. If you take an SSRI, talk to your clinician before considering saffron; it has serotonergic activity.
5. Phosphatidylserine
A 2014 RCT (n=36) in drug-naive children ages 4-14 found 200 mg/day improved ADHD total scores, inattention, and hyperactivity. A 2021 meta-analysis pooling available trials reported an overall effect size of 0.76 that did not reach significance (p=.07). The one subscale that crossed the threshold: inattention (ES 0.36, p=.01). Small trials, inconsistent signal, but the inattention finding is worth watching.
Tier 2: Works as an Add-On, or When You're Deficient
6. Vitamin D
A 2019 meta-analysis of 4 RCTs (n=256) found small but significant improvement in ADHD total scores, inattention, and hyperactivity when vitamin D was added to methylphenidate over 6-12 weeks. Every trial in the meta-analysis used it alongside medication, not alone. And children with ADHD tend to have lower vitamin D levels than controls, so this may be correcting a deficiency rather than producing a nootropic effect.
7. Iron
Get ferritin tested first. The only placebo-controlled iron trial in ADHD, Konofal 2008 (n=23), enrolled non-anemic children ages 5-8 whose ferritin was below 30 ng/mL. Over 12 weeks, ADHD rating scale scores fell 11 points on iron versus rising 3 points on placebo (p<.008). That is a large effect in a tiny, carefully selected sample. If ferritin is above 30, there is no data to support iron supplementation for ADHD, and excess iron carries real risks.
8. Ginkgo Biloba
A 2015 RCT (n=66) in ages 6-12 found that ginkgo plus methylphenidate produced a greater reduction in parent-rated inattention than placebo plus methylphenidate (93.5% vs. 58.6% response rate). On its own, ginkgo was weaker than MPH in an earlier head-to-head. If you take anticoagulants or blood thinners, talk to your prescriber before considering ginkgo; it has well-documented interactions.
Tier 3: Sleep, Not Symptoms
9. Melatonin
Melatonin earns an A grade for sleep onset in children with ADHD, and that is where the story ends. Van der Heijden et al. (2007) randomized 105 medication-free children (ages 6-12) with sleep-onset insomnia: melatonin advanced sleep onset by 26.9 minutes (p<.0001). It had zero effect on behavior, cognition, or quality of life. If the ADHD problem is sleep, melatonin has clean data. If the problem is daytime symptoms, it does not help.
10. L-Theanine
Lyon et al. (2011) gave 400 mg/day of L-theanine to 98 boys with ADHD (ages 8-12) for six weeks: sleep percentage and efficiency improved. No daytime symptom outcome was measured. A 2020 crossover study tested theanine, caffeine, and the combination in boys with ADHD, but the sample was five participants total, too small to draw conclusions from.
For more on dosing, see how much L-theanine is typically used. The broader healthy-adult attention data lives in a separate literature; see the general adult evidence for caffeine and L-theanine together.
Tier 4: Popular, With Thin Evidence
11. Bacopa Monnieri
The Kean 2022 RCT (n=93) tested CDRI 08 extract in boys ages 6-14 over 14 weeks. The headline: no significant behavioral difference versus placebo. The secondary findings were fewer errors (p=.04) and improved cognitive flexibility (p=.01). That is a cognitive benefit without a behavioral benefit, which does not clearly help ADHD symptoms. Read bacopa's full evidence picture outside ADHD for the broader story.
12. Magnesium
The best ADHD trial, Hemamy 2021 (n=66), combined magnesium with vitamin D. Behavioral scores improved (p=.001), but the design cannot separate magnesium's independent effect. That puts magnesium in Grade C: possibly useful, definitely not proven alone for ADHD.
13. Citicoline
The most-cited trial, McGlade 2015 (n=75), found improved attention and psychomotor speed in healthy adolescent males. They did not have ADHD. The study lasted 28 days. Applying those results to an ADHD population requires a leap the data has not made. For dosing details, see typical citicoline dosing. For a related choline source with similar evidence gaps, see Alpha-GPC, a related compound with its own evidence gaps.
14. L-Tyrosine
Reimherr et al. (1987) gave tyrosine to 12 adults with ADHD in an open-label trial. Eight responded within two weeks. All eight lost the effect by week six. That pattern, initial response followed by rapid tolerance, has kept tyrosine stuck at Grade C for nearly forty years. No one has followed up with a larger controlled trial.
Tier 5: No ADHD Trial, or a Null One
15. Caffeine
This one surprises people. A 2023 systematic review identified 7 pediatric RCTs (104 total participants); 4 of those (n = 76) were pooled in a meta-analysis, which reported an SMD of -0.12 (p=.45). The authors concluded caffeine provided "likely no benefit" for managing general ADHD symptoms in children. No adult RCT exists. Caffeine clearly helps alertness in healthy populations, but that effect does not appear to translate to ADHD-specific outcomes.
16. Rhodiola Rosea
A trial was registered (NCT02737020). No results have been posted. That is the entire human ADHD evidence base for rhodiola. Grade D.
17. Creatine
No RCT in an ADHD population exists. Creatine has healthy-adult cognition data (mostly under sleep deprivation or high cognitive load), but it has never been tested in people with ADHD. Grade D.
What to Skip Entirely
Piracetam, noopept, bromantane, and cyclazodone appear in Reddit threads about ADHD stacks. None are lawful U.S. dietary ingredients. None have ADHD RCTs. And nothing on this list, whether graded A or graded D, is a "natural Adderall" or a substitute for a prescription.
How to Stack: Tested Combinations vs. Reddit Builds
No RCT has ever tested a multi-ingredient "ADHD stack." The only combinations with any controlled data are:
- L-theanine + caffeine: tested in 5 boys with ADHD (too small to draw from), plus a large healthy-adult literature.
- Phosphatidylserine + omega-3: one trial, n=200, in children.
- Vitamin D + magnesium: Hemamy 2021, n=66, in children.
Reddit's typical DIY stack (caffeine, L-theanine, L-tyrosine, magnesium, omega-3, vitamin D) is built from single-ingredient data and personal reports, not combination trials. The practical constraints users raise most often: cost and pill burden. Five or six separate bottles adds up, and compliance drops past two or three capsules a day.
"Natural" Nootropics for ADHD: What the Word Buys You
Ginkgo and ginseng are the traditional-medicine entries with trial data on this list. Green tea is the dietary source of L-theanine, though the doses used in the trials above (200-400 mg) are far beyond what a cup of tea delivers (roughly 20-30 mg).
"Natural" tells you where the compound came from. It tells you nothing about whether it works. A 2025 systematic review in Nutrients covering 14 studies concluded that certain supplements show potential as complementary ADHD treatments under clinical guidance. For a broader look at this question, see a broader look at natural ADHD supplements.
Conclusion: What the Evidence Actually Supports
The honest summary: omega-3s have the most data and a small, possibly shrinking effect. Zinc, iron, and vitamin D help if you are deficient. Everything else is either too small, too short, null, or untested in ADHD. No supplement replaces behavioral therapy, exercise, sleep optimization, or medication when medication is indicated.
Before stacking anything, know the interaction and dosing limits: zinc above 40 mg/day long-term can deplete copper, iron without a ferritin test risks overload, ginkgo interacts with anticoagulants, saffron has serotonergic activity that matters if you take an SSRI, and melatonin timing is dose-sensitive. Supplements are unregulated in the U.S. The honest move is to talk to a prescriber before adding anything to your regimen.
Frequently Asked Questions
What are the top 5 supplements for ADHD based on evidence?
Omega-3 (EPA/DHA) ranks first with the most data, though the effect is small. Zinc and iron help if you are deficient. Pycnogenol has two positive RCTs in children. Phosphatidylserine showed a significant effect on inattention in a pooled analysis. None of these replace medication or therapy.
What is the best nootropic stack for ADHD?
No RCT has tested a multi-ingredient ADHD stack. The only combinations with controlled data are L-theanine plus caffeine (n=5, too small), phosphatidylserine plus omega-3 (n=200), and vitamin D plus magnesium (n=66). Building a stack from single-ingredient data is common but unvalidated.
Can green tea help with ADHD?
Green tea contains L-theanine, but a cup provides roughly 20-30 mg. The ADHD sleep trial used 400 mg/day, and the attention crossover used 2.5 mg/kg. You would need 10 to 15 cups to approach trial doses, so a cup of green tea is not replicating the research.
Do nootropics for ADHD work for adults, or only children?
Nearly every RCT above enrolled children. Adult-specific ADHD data is limited to saffron as an add-on (n=56, null result), L-tyrosine (n=12, open-label, effect faded by week 6), and caffeine (cross-sectional surveys only, no adult RCT). The gap is striking.
Is it possible to manage ADHD without medication?
Behavioral therapy, coaching, exercise, and sleep have their own evidence base and are part of clinical guidelines for ADHD management. Supplements represent the weakest layer of the options studied. This ranking describes the evidence; it is not a treatment recommendation.
Are nootropics safe to take with ADHD medication?
That depends entirely on the nootropic and the medication. Ginkgo interacts with blood thinners, saffron has serotonergic effects relevant to SSRIs, and high-dose zinc can affect copper absorption. Talk to your prescriber before combining any supplement with your medication.
The Pairing With the Most Consistent Attention Data (in Healthy Adults)
Of everything ranked above, caffeine and L-theanine together have the most consistent human evidence for attention and alertness. But that evidence comes from healthy adults, not people with ADHD. A 2025 meta-analysis in Nutrition Reviews covering 15 RCTs found the combination improved attention-switching accuracy and alertness in healthy subjects. That is a real finding. It is not an ADHD finding.
Roon delivers that pairing in a sublingual pouch: 80 mg caffeine, 60 mg L-theanine, plus 25 mg methylliberine (Dynamine) and 5 mg theacrine (TeaCrine). Methylliberine slows caffeine's clearance. In a randomized, double-blind crossover PK study (n=12), co-administration cut caffeine's oral clearance from 41.9 to 17.1 L/hr and extended its half-life from 7.2 to 15 hours, with no increase in peak concentration. That study used 100 mg methylliberine and 150 mg caffeine, roughly 4x and 1.9x what Roon contains, so the 6-to-8-hour felt window is directionally consistent with the mechanism rather than a direct readout of the study. A longer half-life also means you should stop at least 8 hours before bed.
Roon is not a treatment for ADHD. It is not a substitute for medication. It does not replace a clinician's care plan. It is a zero-sugar, zero-nicotine focus pouch for people who want steady alertness, starting from $9.16 per tin subscribed ($0.61/pouch), or $15.00/tin one-time ($1.00/pouch), with a 30-day money-back guarantee on a first order.
Related from Roon
- https://www.takeroon.com/blog/l-theanine-caffeine-adhd
- https://www.takeroon.com/blog/natural-adhd-supplements-science-based-guide
- https://www.takeroon.com/blog/caffeine-and-l-theanine
- https://www.takeroon.com/blog/alpha-gpc-for-adhd
Written by Roon Team






